Portage BioTech Inc.

Recent News

  • Portage Announces Filing of Q1 Interim Financial Statements; Correction to SalvaRX Loan Note Settlement Announcement

    Toronto, Ontario--(Newsfile Corp. - October 16, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") announces that the Company has filed its interim financial statements and related management's discussion and analysis for the three-month period ending June 30, 2020 and related delivery requirements (the "Q1 Filings").Previously on August 28, 2020, Portage announced that pursuant to blanket relief granted by the Canadian Securities Administrators, it would not file the Q1 Filings by the filing deadline...

    2020-10-16 4:01 PM ET
  • Portage Issues Common Shares and Warrants in Settlement of SalvaRx Loan Note Obligations

    Toronto, Ontario--(Newsfile Corp. - October 13, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") wishes to announce that it has issued 375,014 common shares at a deemed price of US$6.64 per common share and 72,291 common share purchase warrants exercisable at a price of $6.64 per common share for a period of 2 years (collectively, the "Settlement Securities") to settle approximately US$4.4 million of certain debt obligations and equity entitlements (the "Loan Notes")...

    2020-10-13 8:00 AM ET
  • Portage Announces Reliance on Temporary Regulatory Relief for Filing Q1 Interim Financial Statements

    Toronto, Ontario--(Newsfile Corp. - August 28, 2020) -  Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") wishes to announce that it will be utilizing the extension period provided under Ontario Instrument 51-505 - Temporary Exemption from Certain Corporate Finance Requirements with Deadlines during the Period from June 2 to August 31, 2020 ("Instrument 51- 505") and similar extension periods provided for by the Canadian Securities Administrators in the other provinces and territories of Canada for the...

    2020-08-28 5:45 PM ET
  • Portage Announces Filing of Annual Financial Statements

    Reflecting significant strengthening of Company's fundamentalsPipeline progressing: anticipate 3 clinical programs by year endFinancial resources enable accelerated development and opportunistic value creation Toronto, Ontario--(Newsfile Corp. - August 24, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") announces that the Company has filed its annual financial statements for the fiscal year ended March 31, 2020, related management's discussion and analysis and officer certifications, as required by Parts 4 and 5 of National Instrument 51-102 ...

    2020-08-24 8:00 AM ET
  • Portage Announces Reliance on Temporary Regulatory Relief for Filing Annual Financial Statements

    Toronto, Ontario--(Newsfile Corp. - July 28, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") announces that it is utilizing the extension period provided under Ontario Instrument 51-505 - Temporary Exemption from Certain Corporate Finance Requirements with Deadlines during the Period from June 2 to August 31, 2020 ("Instrument 51- 505"), and similar extension periods provided for by the Canadian Securities Administrators in the other provinces and territories of Canada, for (i) filing its...

    2020-07-28 8:07 PM ET